We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Unique Dye-Based Tests to Revolutionize Early-Detection Pancreatic Cancer Diagnostics

By LabMedica International staff writers
Posted on 17 Mar 2023
Print article
Image: New diagnostic tests could accurately detect and pre-empt risks of debilitating diseases (Photo courtesy of Amplified Sciences)
Image: New diagnostic tests could accurately detect and pre-empt risks of debilitating diseases (Photo courtesy of Amplified Sciences)

Pancreatic cancer is the third deadliest cancer, with 74 out of every 100 patients succumbing to it within a year of diagnosis as it is often detected too late to be treated effectively. Now, that could change with the development of new tests that use dyes to detect the possibility of malignancy in fluid extracted from pancreatic cysts. When appropriately evaluated, these cysts can provide a means of detecting pancreatic cancer at an earlier stage.

Amplified Sciences Inc. (West Lafayette, IN, USA) is currently developing a range of diagnostic tests for early cancer detection, specifically designed to identify the likelihood of cancer development. Not only can these tests confirm the absence of malignancy in patients with cysts, but they could also reduce the number of inaccurate diagnoses and alleviate patient concerns. The company has successfully conducted clinical trials on its pancreatic cancer test which is now poised for translation to a clinical lab and to enter the regulatory process.

While the future for these early cancer detection tests appears promising, there are also practical challenges that must be addressed. In addition to laboratory-related obstacles, the successful regulatory approval of these tests could necessitate the training of more gastroenterologists to collect fluid from pancreatic cysts, a procedure that is not usually included in standard medical school training for all gastroenterologists.

“Earlier detection, followed by surgical removal, has a much better prognosis,” said Diana Caldwell, Amplified Sciences’ chief executive officer. “We also hope that, with early detection, scientists can identify interventions that can impact early stage pancreatic cancer. That’s a principle of cancer treatment – the earlier you get it, the more likely pharmaceuticals and other therapies are able to resolve it.”

Related Links:
Amplified Sciences Inc.

Flocked Swab
HydraFlock and PurFlock Ultra
Gold Supplier
Microscopes and Accessories
Euromex
New
UHF RFID Tag and Inlay
AD-163u8
New
PCR Fluorescent Quantitative System
AccuRa mini

Print article

Channels

Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Hematology

view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more

Immunology

view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more

Microbiology

view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more

Pathology

view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more

Technology

view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more

Industry

view channel
Image: The global hemostasis diagnostics market is expected to reach USD 3.95 billion by 2025 (Photo courtesy of Freepik)

Global Hemostasis Diagnostics Market Driven by Increase in Invasive Surgical Procedures

Injury or surgery naturally creates bleeding in living beings, which must be stopped to prevent excessive blood loss. The human body implements a protective mechanism known as hemostasis to stop excessive bleeding.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.